Genpharmasec Ltd — Board Meeting, 09-02-2026: Board Meeting
09-02-2026 | 04:50 pm
09-02-2026 | 04:50 pm
GENPHARMASEC's board approved the financial results for the quarter and nine months. Consolidated total income reached ₹3.98 Cr with a net loss of ₹0.04 Cr. Standalone net profit was ₹0.76 Cr.
No comments yet. Be the first to comment!
